See more : Medicus Pharma Ltd. Warrant (MDCXW) Income Statement Analysis – Financial Results
Complete financial analysis of Ladun Investment Company (9535.SR) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Ladun Investment Company, a leading company in the Real Estate – Development industry within the Real Estate sector.
- PLANT Co.,Ltd. (7646.T) Income Statement Analysis – Financial Results
- Jinlihua Electric Co., Ltd. (300069.SZ) Income Statement Analysis – Financial Results
- Cheviot Company Limited (CHEVIOT.NS) Income Statement Analysis – Financial Results
- IMS S.A. (IMS.WA) Income Statement Analysis – Financial Results
- Agile Therapeutics, Inc. (AGRX) Income Statement Analysis – Financial Results
Ladun Investment Company (9535.SR)
About Ladun Investment Company
Founded in 2004, The Company has continued its successes and achievements to become a Saudi joint stock company with a capital of SAR 500,000,000, the company has a long experience in the development and management of real estate assets and through its long career has succeeded in creating qualitative partnerships in the field of real estate development and constantly seeking to develop new standards for the implementation of commercial, residential and mixed-use projects while maintaining the principles of quality design, innovation and sustainability in accordance with the best leading standards.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1.44B | 881.18M | 769.82M | 527.02M | 205.05M |
| Cost of Revenue | 1.14B | 714.12M | 666.97M | 421.22M | 155.79M |
| Gross Profit | 298.09M | 167.06M | 102.85M | 105.80M | 49.26M |
| Gross Profit Ratio | 20.76% | 18.96% | 13.36% | 20.07% | 24.02% |
| Research & Development | 0.00 | 0.08 | 0.12 | 0.06 | 0.00 |
| General & Administrative | 13.58M | 13.87M | 18.24M | 19.37M | 17.11M |
| Selling & Marketing | 205.45K | 148.72K | 601.26K | 2.49M | 1.40M |
| SG&A | 13.79M | 79.72M | 59.75M | 21.85M | 18.52M |
| Other Expenses | 130.39M | -89.63M | -65.77M | 51.96M | 46.54M |
| Operating Expenses | 144.18M | -89.63M | -65.77M | 73.81M | 65.06M |
| Cost & Expenses | 1.28B | 714.12M | 666.97M | 495.03M | 220.85M |
| Interest Income | 0.00 | 18.77M | 9.98M | 1.17M | |
| Interest Expense | 30.15M | 24.92M | 21.05M | 12.84M | |
| Depreciation & Amortization | -2.25M | 38.23M | 37.58M | 50.74M | 44.66M |
| EBITDA | 151.67M | 128.46M | 86.73M | 87.98M | 44.80M |
| EBITDA Ratio | 10.56% | 10.40% | 15.13% | 19.30% | 21.85% |
| Operating Income | 153.91M | 77.43M | 37.08M | 50.98M | 864.06K |
| Operating Income Ratio | 10.72% | 8.79% | 4.82% | 9.67% | 0.42% |
| Total Other Income/Expenses | -32.39M | -10.73M | 59.53M | -2.03M | 15.08M |
| Income Before Tax | 121.52M | 66.70M | 95.41M | 29.80M | -899.37K |
| Income Before Tax Ratio | 8.46% | 7.57% | 12.39% | 5.65% | -0.44% |
| Income Tax Expense | 12.18M | 6.51M | 14.61M | 4.99M | 5.60M |
| Net Income | 109.34M | 60.19M | 80.80M | 24.82M | -6.50M |
| Net Income Ratio | 7.61% | 6.83% | 10.50% | 4.71% | -3.17% |
| EPS | 0.22 | 0.12 | 0.16 | 0.05 | -0.01 |
| EPS Diluted | 0.22 | 0.12 | 0.16 | 0.05 | -0.01 |
| Weighted Avg Shares Out | 500.00M | 500.00M | 500.00M | 500.00M | 500.00M |
| Weighted Avg Shares Out (Dil) | 500.00M | 500.00M | 500.00M | 500.00M | 500.00M |
Source: https://incomestatements.info
Category: Stock Reports